The chloroform extract of Zaluzania robinsonii Sharp has shown activity against the P‐388 lymphocytic leukemia test system. The constituent responsible for this activity was a guaianolide, identified as zaluzanin C (15H18O3). The identity was proven by melting point, mixed melting point, elemental analysis, IR, PMR, mass spectroscopy, and preparation of derivatives.
- Antitumor agents, potential—isolation, identification, and screening of zaluzanin C from Z. robinsonii
- Zaluzania robinsonii (Compositae)—isolation and identification of zaluzanin C as tumor‐inhibiting agent
- Zaluzanin C‐isolation and identification from Z. robinsonii, tested for tumor‐inhibitory activity
ASJC Scopus subject areas
- Pharmaceutical Science